InnoPharmax
About
About Us
Organization
Our History
News
News
R&D
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Products
GemOral
N11005
Technologies
OralPAS®
OralPAS Pro®
MUCR™
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
ZH-TW
Product and Pipeline
Pipeline
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Gadomni® (Gadopentetate dimeglumine)
>
Contrast Agents
>
Product and Pipeline
>
home
Gadomni® (Gadopentetate dimeglumine)
Gadomni
®
(Gadopentetate dimeglumine)
Clicks:
6651
Gadopentetate dimeglumine is a contrast medium for magnetic resonance imaging (MRI) of the body after intravenous administration. It is often used when viewing intracranial lesions with abnormal vascularity or abnormalities in the blood-brain barrier. Its paramagnetic property reduces the T1 relaxation time (and to some extent the T2 relaxation time) in NMR, which is the source of its clinical utility. In August 2007,
INNOPHARMAX
had been granted the product license from DOH to market
GADOMNI
®
in Taiwan.
Back
uGear Design
-
Website Info.